MAST Biosurgery Overview
- Year Founded
-
2004
- Status
-
Private
- Employees
-
26
- Latest Deal Type
-
2ndary - Private
MAST Biosurgery General Information
Description
Developer of bioresorbable polymer implants designed for surgical applications. The company's offerings include surgical thin sheets for soft tissue applications and bioresorbable protective sheets for the management and protection of tendon injuries and post-surgical healing, enabling the medical community to facilitate the healing of larger tissue masses and eliminate adverse effects of permanent implants.
Contact Information
Website
www.mastbio.comCorporate Office
- Claridenstrasse 25
- 8002 Zurich
- Switzerland
Corporate Office
- Claridenstrasse 25
- 8002 Zurich
- Switzerland
MAST Biosurgery Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | 01-May-2022 | Completed | Generating Revenue | |||
| 1. Later Stage VC | 01-Apr-2014 | Completed | Startup |
MAST Biosurgery Comparisons
Industry
Financing
Details
MAST Biosurgery Competitors (12)
One of MAST Biosurgery’s 12 competitors is TISSIUM, a Venture Capital-Backed company based in Paris, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| TISSIUM | Venture Capital-Backed | Paris, France | ||||
| Confluent Medical Technologies | Formerly PE-Backed | Scottsdale, AZ | ||||
| Ingenyx | Private Equity-Backed | Plymouth, MN | ||||
| Elixir Medical | Venture Capital-Backed | Milpitas, CA | ||||
| Pfm Medical (Germany) | Corporation | Cologne, Germany |
MAST Biosurgery Patents
MAST Biosurgery Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20130052236-A1 | Composite polylactic acid/alginate surgical barrier | Inactive | 30-Aug-2011 | ||
| WO-2013033168-A1 | Polyactic acid/alginate containing surgical barrier | Inactive | 30-Aug-2011 | ||
| US-20120039959-A1 | Anti-adhesion alginate barrier of variable absorbance | Inactive | 16-Aug-2010 | ||
| WO-2012024339-A1 | Anti-adhesion alginate barrier of variable absorbance | Inactive | 16-Aug-2010 | ||
| AU-2011264797-A1 | Adhesion-resistant surgical access, reinforcement and closure prosthetic | Inactive | 09-Jun-2010 | A61B17/0057 |
MAST Biosurgery Signals
MAST Biosurgery FAQs
-
When was MAST Biosurgery founded?
MAST Biosurgery was founded in 2004.
-
Where is MAST Biosurgery headquartered?
MAST Biosurgery is headquartered in Zurich, Switzerland.
-
What is the size of MAST Biosurgery?
MAST Biosurgery has 26 total employees.
-
What industry is MAST Biosurgery in?
MAST Biosurgery’s primary industry is Surgical Devices.
-
Is MAST Biosurgery a private or public company?
MAST Biosurgery is a Private company.
-
What is MAST Biosurgery’s current revenue?
The current revenue for MAST Biosurgery is .
-
Who are MAST Biosurgery’s competitors?
TISSIUM, Confluent Medical Technologies, Ingenyx, Elixir Medical, and Pfm Medical (Germany) are some of the 12 competitors of MAST Biosurgery.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process